Figure 1.
Figure 1. Incidence of VZV reactivation over time in CLL patients treated with front-line BR who received antiviral prophylaxis.

Incidence of VZV reactivation over time in CLL patients treated with front-line BR who received antiviral prophylaxis.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal